Sun Pharmaceutical Industries Limited has announced the appointment of Kirti Ganorkar as Managing Director, effective September 1, 2025. He will take over the role from Dilip Shanghvi, marking a key leadership transition at India’s largest pharmaceutical company. All business and functional teams will report to Ganorkar following the appointment.
Shanghvi to Continue as Executive Chairman
While stepping down as MD, Dilip Shanghvi will continue to serve as Executive Chairman, leading the Board and focusing on the company’s long-term strategic direction. He will also play a pivotal role in expanding Sun Pharma’s specialty portfolio, a key area of growth for the company. The transition reflects a well-planned succession process, reinforcing Sun Pharma’s commitment to leadership continuity and sound governance.
Ganorkar Brings Proven Leadership Track Record
Ganorkar has been leading Sun Pharma’s India Business since June 2019, during which the company consistently increased its market share and performance. A Sun Pharma veteran who joined the company in 1996, he has held several key roles across business development, marketing, M&A, project management, intellectual property, and litigation.
Driving Strategic Growth Across Markets
Ganorkar played a crucial role in securing rights for specialty drugs such as Ilumya, spearheading Sun Pharma’s entry into the Japanese market, and laying the foundation for its expansion in Europe. He also supported major generic projects for the U.S. pharmaceutical market, further strengthening the company’s global footprint.
Experienced, Visionary Leader with Strong Credentials
Ganorkar brings both technical expertise and strategic vision to his new role. His deep understanding of global markets and product pipelines makes him well-positioned to lead Sun Pharma through its next phase of growth and innovation.
A Milestone in Sun Pharma’s Leadership Evolution
The leadership change marks a significant milestone in Sun Pharma’s journey, signalling both continuity and renewal. As reported by fortuneindia.com, with Ganorkar at the operational helm and Shanghvi guiding strategic direction, the company is well-equipped to navigate future challenges and capitalize on new growth opportunities in the global healthcare landscape.
